The Architecture of Decentralized Trials: Integrating Regenerative Medicine and Patient Recovery
Clinical trial architecture is experiencing a fundamental structural shift across the pharmaceutical and biotechnology landscapes. For decades, traditional clinical development relied almost exclusively on large academic medical centers, requiring trial subjects to endure frequent travel, rigid scheduling, and burdensome on-site hospital visits. In complex therapeutic fields such as regenerative medicine, tissue repair, and metabolic recovery,










